Abstract
Accurately predicting sensitivity of tumor cells to anti-cancer drugs based on genetic characterizations is a significant challenge for personalized cancer therapy. This chapter provides a computational procedure to design predictive models from individual genomic characterizations and combine them to arrive at an integrated predictive model. Integrated modeling employs the complementary information from heterogeneous genetic characterizations to improve the prediction error as well as lowering the error confidence interval.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Costello JC et al (2014) A community effort to assess and improve drug sensitivity prediction algorithms. Nat Biotechnol. https://doi.org/10.1038/nbt.2877
Wan Q, Pal R (2014) An ensemble based top performing approach for NCI-dream drug sensitivity prediction challenge. PLoS One 9(6):e101183
Sos ML, Michel K, Zander T, Weiss J, Frommolt P, Peifer M, Li D, Ullrich R, Koker M, Fischer F, Shimamura T, Rauh D, Mermel C, Fischer S, Stückrath I, Heynck S, Beroukhim R, Lin W, Winckler W, Shah K, LaFramboise T, Moriarty WF, Hanna M, Tolosi L, Rahnenführer J, Verhaak R, Chiang D, Getz G, Hellmich M, Wolf J, Girard L, Peyton M, Weir BA, Chen TH, Greulich H, Barretina J, Shapiro GI, Garraway LA, Gazdar AF, Minna JD, Meyerson M, Wong KK, Thomas RK (2009) Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest 119(6):1727–1740
Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES, Golub TR (2001) Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci 98:10787–10792
Lee JK, Havaleshko DM, Cho H, Weinstein JN, Kaldjian EP, Karpovich J, Grimshaw A, Theodorescu D (2007) A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc Natl Acad Sci 104(32):13086–13091
Mitsos A, Melas IN, Siminelakis P, Chairakaki AD, Saez-Rodriguez J, Alexopoulos LG (2009) Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput Biol 5(12):e1000591+
Walther Z, Sklar J (2011) Molecular tumor profiling for prediction of response to anticancer therapies. Cancer J 17(2):71–79
Zou H, Hastie T (2005) Regularization and variable selection via the elastic net. J R Stat Soc Ser B 67:301–320
Barretina J et al (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603–607
Riddick G, Song H, Ahn S, Walling J, Borges-Rivera D, Zhang W, Fine HA (2011) Predicting in vitro drug sensitivity using Random Forests. Bioinformatics 27(2):220–224
Bengtsson H, Simpson K, Bullard J, Hansen K (2008) aroma.affymetrix: a generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. Tech. Rep. 745, Department of Statistics, University of California, Berkeley
Garber M, Grabherr MG, Guttman M, Trapnell C (2011) Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods 8(6):469–477
Wilhelm BT, Landry JR (2009) RNA-seq-quantitative measurement of expression through massively parallel RNA-sequencing. Methods 48(3):249–257
Li S, Tighe SW, Nicolet CM, Grove D, Levy S, Farmerie W, Viale A, Wright C, Schweitzer PA, Gao Y, Kim D, Boland J, Hicks B, Kim R, Chhangawala S, Jafari N, Raghavachari N, Gandara J, Garcia-Reyero N, Hendrickson C, Roberson D, Rosenfeld J, Smith T, Underwood JG, Wang M, Zumbo P, Baldwin DA, Grills GS, Mason CE (2014) Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study. Nat Biotechnol 32(9):915–925
Xie F, Liu T, Qian WJ, Petyuk VA, Smith RD (2011) Liquid chromatography-mass spectrometry-based quantitative proteomics. J Biol Chem 286(29):25443–25449
Li F, Gonzalez FJ, Ma X (2012) LC–MS-based metabolomics in profiling of drug metabolism and bioactivation. Acta Pharm Sin B 2(2):118–125. Drug Metabolism and Transport
Troyanskaya OG, Cantor MN, Sherlock G, Brown PO, Hastie T, Tibshirani R, Botstein D, Altman RB (2001) Missing value estimation methods for DNA microarrays. Bioinformatics 17(6):520–525
Berlow N, Haider S, Wan Q, Geltzeiler M, Davis LE, Keller C, Berlow RN (2014) An integrated approach to anti-cancer drugs sensitivity prediction. IEEE/ACM Trans Comput Biol Bioinform. https://doi.org/10.1155/2014/873436
Berlow N, Davis LE, Cantor EL, Seguin B, Keller C, Pal R (2013) A new approach for prediction of tumor sensitivity to targeted drugs based on functional data. BMC Bioinformatics 14:239
Robnik-Sikonja M, Kononenko I (1997) An adaptation of relief for attribute estimation in regression. In: Proceedings of the fourteenth international conference on machine learning (ICML ’97). Morgan Kaufmann Publishers Inc, San Francisco, pp 296–304
Šikonja MR, Kononenko I (2003) Theoretical and empirical analysis of ReliefF and RReliefF. Mach Learn 53(1–2):23–69
Zarrinkar PP, Gunawardane RN, Cramer MD, Gardner MF, Brigham D, Belli B, Karaman MW, Pratz KW, Pallares G, Chao Q, Sprankle KG, Patel HK, Levis M, Armstrong RC, James J, Bhagwat SS (2009) AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood 114(14):2984–2992
Fabian MA, Biggs WH, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, Carter TA, Ciceri P, Edeen PT, Floyd M, Ford JM, Galvin M, Gerlach JL, Grotzfeld RM, Herrgard S, Insko DE, Insko MA, Lai AG, Lelias JM, Mehta SA, Milanov ZV, Velasco AM, Wodicka LM, Patel HK, Zarrinkar PP, Lockhart DJ (2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23(3):329–336
Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, Faraoni R, Floyd M, Hunt JP, Lockhart DJ, Milanov ZV, Morrison MJ, Pallares G, Patel HK, Pritchard S, Wodicka LM, Zarrinkar PP (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26(1):127–132
Breiman L (2001) Random forests. Mach Learn 45(1):5–32
Meinshausen N (2006) Quantile regression forests. J Mach Learn Res 7:983–999
Biau G (2012) Analysis of a random forests model. J Mach Learn Res 98888:1063–1095
Shalabi LA, Shaaban Z, Kasasbeh B (2006) Data mining: a preprocessing engine. J Comput Sci 2(9):735
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rahman, R., Pal, R. (2019). Predictive Modeling of Anti-Cancer Drug Sensitivity from Genetic Characterizations. In: Krasnitz, A. (eds) Cancer Bioinformatics. Methods in Molecular Biology, vol 1878. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8868-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8868-6_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8866-2
Online ISBN: 978-1-4939-8868-6
eBook Packages: Springer Protocols